Skip to main content
DOC
NYSE Real Estate & Construction

Healthpeak Properties Raises 2026 EPS Guidance, Reports Strong Q1 Results, and Finalizes Janus Living IPO

Analysis by Arik Shkolnikov
Sentiment info
Positive
Importance info
9
Price
$16.65
Mkt Cap
$11.759B
52W Low
$15.7
52W High
$19.68
Market data snapshot near publication time

summarizeSummary

Healthpeak Properties reported strong Q1 2026 results, raised its full-year EPS and FFO as Adjusted guidance, and successfully completed the Janus Living IPO, generating $880 million in net proceeds for accretive investments and share repurchases.


check_boxKey Events

  • Q1 2026 Financial Performance

    Reported net income of $0.28 per share, Nareit FFO of $0.42 per share, and FFO as Adjusted of $0.45 per share. Consolidated revenue grew 35% year-over-year, and Adjusted EBITDAre increased by 42%.

  • Raised 2026 Earnings Guidance

    Updated full-year 2026 diluted EPS guidance from $0.34-$0.38 to $0.46-$0.50 and diluted FFO as Adjusted per share from $1.70-$1.74 to $1.71-$1.75. Diluted Nareit FFO per share guidance was slightly adjusted from $1.70-$1.74 to $1.68-$1.72.

  • Janus Living IPO Completion

    Janus Living, Inc. completed its initial public offering in March 2026, generating approximately $880 million in net proceeds. Healthpeak retains an 81.6% equity ownership in Janus Living, which had a market capitalization of $6.9 billion as of May 4, 2026.

  • Strategic Capital Allocation

    Closed on $714 million in senior housing acquisitions across 25 communities, contributed to Janus Living. Generated $267 million in net proceeds from recapitalizations, dispositions, and loan repayments, including selling an 80% joint venture interest in a $212 million outpatient medical portfolio to Blackstone for $170 million.


auto_awesomeAnalysis

Healthpeak Properties delivered a strong first quarter, marked by the successful completion of the Janus Living IPO and strategic capital allocation. The company raised its full-year 2026 diluted EPS and FFO as Adjusted guidance, signaling improved profitability and operational efficiency. The IPO of Janus Living generated substantial proceeds and is expected to benefit Healthpeak's earnings growth through its retained majority stake and accretive acquisition opportunities. Significant capital recycling activities, including senior housing acquisitions and an outpatient medical joint venture with Blackstone, demonstrate a proactive approach to portfolio optimization and shareholder value creation. The share repurchase program further underscores management's confidence.

At the time of this filing, DOC was trading at $16.65 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $11.8B. The 52-week trading range was $15.70 to $19.68. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed DOC - Latest Insights

DOC
May 06, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
9
DOC
May 05, 2026, 4:43 PM EDT
Source: Reuters
Importance Score:
8
DOC
May 05, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
9
DOC
May 05, 2026, 4:15 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
DOC
Mar 23, 2026, 4:34 PM EDT
Source: Reuters
Importance Score:
7
DOC
Mar 23, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
8
DOC
Mar 16, 2026, 7:27 AM EDT
Source: Reuters
Importance Score:
8
DOC
Mar 12, 2026, 4:28 PM EDT
Filing Type: DEF 14A
Importance Score:
7
DOC
Feb 03, 2026, 4:31 PM EST
Filing Type: 10-K
Importance Score:
8
DOC
Feb 02, 2026, 4:18 PM EST
Filing Type: 8-K
Importance Score:
8